(NASDAQ: STIM) Neuronetics's forecast annual revenue growth rate of 12.24% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 8.47%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.13%.
Neuronetics's revenue in 2026 is $151,636,000.On average, 5 Wall Street analysts forecast STIM's revenue for 2026 to be $11,532,096,845, with the lowest STIM revenue forecast at $11,006,708,653, and the highest STIM revenue forecast at $11,909,958,816. On average, 5 Wall Street analysts forecast STIM's revenue for 2027 to be $12,906,456,685, with the lowest STIM revenue forecast at $11,838,979,219, and the highest STIM revenue forecast at $13,875,815,296.
In 2028, STIM is forecast to generate $15,132,571,686 in revenue, with the lowest revenue forecast at $14,539,683,290 and the highest revenue forecast at $15,577,933,862.